PubRank

Ivo A Olivotto

Author PubWeight™ 114.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005 5.65
2 Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med 2015 4.94
3 Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival. J Clin Oncol 2006 3.42
4 Time to stop progesterone receptor testing in breast cancer management. J Clin Oncol 2004 3.33
5 Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004 3.21
6 The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer 2007 2.84
7 Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol 2002 2.75
8 Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clin Cancer Res 2004 2.51
9 Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol 2006 2.49
10 Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 2006 2.38
11 Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers. J Clin Oncol 2008 2.38
12 Consensus conference on breast conservation. J Am Coll Surg 2006 2.17
13 Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes. Int J Radiat Oncol Biol Phys 2010 2.08
14 Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 2002 2.04
15 The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 2005 1.95
16 Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Int J Radiat Oncol Biol Phys 2009 1.70
17 Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies. J Clin Oncol 2004 1.61
18 Impact of routine pathology review on treatment for node-negative breast cancer. J Clin Oncol 2012 1.59
19 Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. J Clin Oncol 2010 1.59
20 Is mastectomy superior to breast-conserving treatment for young women? Int J Radiat Oncol Biol Phys 2007 1.58
21 Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer. Int J Radiat Oncol Biol Phys 2002 1.50
22 Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer? Int J Radiat Oncol Biol Phys 2007 1.49
23 Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 2005 1.47
24 Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ 2004 1.46
25 Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia. Lung Cancer 2004 1.43
26 Does a three-field electron/minitangent photon technique offer dosimetric advantages to a multifield, photon-only technique for accelerated partial breast irradiation? Am J Clin Oncol 2010 1.39
27 Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer 2003 1.38
28 Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 2005 1.36
29 Target volume delineation for partial breast radiotherapy planning: clinical characteristics associated with low interobserver concordance. Int J Radiat Oncol Biol Phys 2007 1.34
30 The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. Gynecol Oncol 2005 1.27
31 Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis. J Clin Oncol 2005 1.24
32 The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 2007 1.21
33 Reliability and validity testing of the Patient and Observer Scar Assessment Scale in evaluating linear scars after breast cancer surgery. Plast Reconstr Surg 2007 1.19
34 Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 2003 1.15
35 A population-based study of the fractionation of postlumpectomy breast radiation therapy. In regard to Ashworth et al. Int J Radiat Oncol Biol Phys 2013 1.13
36 Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence. Breast Cancer Res Treat 2008 1.12
37 Consistency in seroma contouring for partial breast radiotherapy: impact of guidelines. Int J Radiat Oncol Biol Phys 2006 1.11
38 Declining use of mastectomy for invasive breast cancer in Canada, 1981-2000. Can J Public Health 2004 1.08
39 Preliminary reliability and validity testing of a new Skin Toxicity Assessment Tool (STAT) in breast cancer patients undergoing radiotherapy. Am J Clin Oncol 2004 1.07
40 Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy. Int J Radiat Oncol Biol Phys 2005 0.98
41 Effect of community population size on breast cancer screening, stage distribution, treatment use and outcomes. Can J Public Health 2012 0.98
42 Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy. J Am Coll Surg 2005 0.98
43 Satisfaction and anxiety for women during investigation of an abnormal screening mammogram. Breast Cancer Res Treat 2002 0.97
44 When is CT-based postoperative seroma most useful to plan partial breast radiotherapy? Evaluation of clinical factors affecting seroma volume and clarity. Int J Radiat Oncol Biol Phys 2008 0.97
45 Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation. Am J Surg 2003 0.96
46 Postmastectomy radiation therapy: who needs it? J Clin Oncol 2004 0.96
47 Outcomes of sentinel node biopsy for breast cancer in British Columbia, 1996 to 2001. Am J Surg 2003 0.95
48 Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer. Am J Surg 2006 0.94
49 A case-match study comparing unilateral with synchronous bilateral breast cancer outcomes. J Clin Oncol 2011 0.94
50 Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen. Cancer 2008 0.93
51 3D ultrasound can contribute to planning CT to define the target for partial breast radiotherapy. Int J Radiat Oncol Biol Phys 2008 0.93
52 Does the intent to irradiate the internal mammary nodes impact survival in women with breast cancer? A population-based analysis in British Columbia. Int J Radiat Oncol Biol Phys 2012 0.91
53 Effect of nodal irradiation and fraction size on cardiac and cerebrovascular mortality in women with breast cancer treated with local and locoregional radiotherapy. Int J Radiat Oncol Biol Phys 2010 0.91
54 Increased use of adjuvant regional radiotherapy for node-positive breast cancer in British Columbia. Breast J 2004 0.90
55 Staging reclassification affects breast cancer survival. J Clin Oncol 2003 0.90
56 Correction of systematic setup errors in prostate radiation therapy: how many images to perform? Med Dosim 2005 0.88
57 Endoscopic response predicts for survival and organ preservation after primary chemoradiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 2003 0.88
58 Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : comparison of cohorts treated with and without tamoxifen. Cancer 2007 0.88
59 Locoregional recurrence risks in elderly breast cancer patients treated with mastectomy without adjuvant radiotherapy. Eur J Cancer 2005 0.87
60 Proceedings of the Consensus Conference on Breast Conservation, April 28 to May 1, 2005, Milan, Italy. Cancer 2006 0.86
61 A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer. Int J Radiat Oncol Biol Phys 2004 0.86
62 Which prediction models best identify additional axillary disease after a positive sentinel node biopsy for breast cancer? Breast Cancer Res Treat 2012 0.86
63 Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. Eur J Cancer 2005 0.85
64 Standardized audiotape versus recorded consultation to enhance informed consent to a clinical trial in breast oncology. Psychooncology 2007 0.85
65 Standardized assessment of breast cancer surgical scars integrating the Vancouver Scar Scale, Short-Form McGill Pain Questionnaire, and patients' perspectives. Plast Reconstr Surg 2005 0.85
66 Facilitated "fast track" referral reduces time from abnormal screening mammogram to diagnosis. Can J Public Health 2008 0.85
67 Simultaneous couch and gantry dynamic arc rotation (CG-Darc) in the treatment of breast cancer with accelerated partial breast irradiation (APBI): a feasibility study. J Appl Clin Med Phys 2013 0.84
68 Effect of radiotherapy boost and hypofractionation on outcomes in ductal carcinoma in situ. Cancer 2010 0.84
69 Are the creation and maintenance of databases in healthcare worthwhile? An example of a unique, population-based, radiation therapy database. Healthc Q 2012 0.83
70 Increased use of regional radiotherapy is associated with improved outcome in a population-based cohort of women with breast cancer with 1-3 positive nodes. Radiother Oncol 2010 0.82
71 Predictors of local recurrence in a population-based cohort of women with ductal carcinoma in situ treated with breast conserving surgery alone. Ann Surg Oncol 2010 0.82
72 Management and outcomes of isolated axillary node recurrence in breast cancer. Arch Surg 2006 0.79
73 Impact of quality assurance rounds in a Canadian radiation therapy department. Int J Radiat Oncol Biol Phys 2012 0.79
74 Measuring surgeon performance of sentinel lymph node biopsy in breast cancer treatment by cumulative sum analysis. Am J Surg 2007 0.79
75 Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med 2015 0.79
76 Proceedings of the consensus conference on breast conservation, Milan, Italy, April 28-May 1, 2005. Int J Radiat Oncol Biol Phys 2006 0.79
77 The quality of life of elderly women who underwent radiofrequency ablation to treat breast cancer. Qual Health Res 2006 0.78
78 A low-dose ipsilateral lung restriction improves 3-d conformal planning for partial breast radiation therapy. Med Dosim 2010 0.78
79 Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia. J Med Screen 2008 0.77
80 Local and regional therapy for women with breast cancer in British Columbia. Breast J 2003 0.76
81 Consensus conference on breast conservation, Milan, Italy, April 28-May 1, 2005. Breast J 2006 0.76
82 Is breast conservation therapy superior to mastectomy for women with triple-negative breast cancers? J Clin Oncol 2011 0.76
83 Examining time intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer. Am J Clin Oncol 2006 0.76
84 The impact of dose calculation algorithms on partial and whole breast radiation treatment plans. Radiat Oncol 2010 0.75
85 A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy. Breast 2012 0.75
86 In regard to Fortin et al., Int J Radiat Oncol Biol Phys 2003;56:1013-1022. Int J Radiat Oncol Biol Phys 2004 0.75
87 Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. Hered Cancer Clin Pract 2005 0.75
88 Practice patterns of lymph-node mapping and sentinel-node biopsy for breast cancer in British Columbia. Can J Surg 2003 0.75
89 T1a breast carcinoma and the role of axillary dissection. Arch Surg 2003 0.75
90 Effectiveness of a letter notification program for women with early-stage breast cancer eligible for extended adjuvant letrozole. J Clin Oncol 2009 0.75
91 Communication during breast cancer treatment. BMJ 2009 0.75